Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma

Código QR

Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma

Zhi-He Liu,1 Lin Zhang,2 Fan-Jing Jing,1 Shu-Xin Xiao,1 Yan Gao,1 Hai-Yan Bian,1 Xia Zhao1 1Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People’s Republic of China; 2Laboratory of Molecular Diagnosis and Regenerative Medicine, The Affiliated Hos...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liu ZH, Zhang L, Jing FJ, Xiao SX, Gao Y, Bian HY, Zhao X
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	nlrp3 inflammasome b-cell non-hodgkin’s lymphoma susceptibility survival Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/3f7a24b1e33542c5a25ec5a20086163f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Spotlight on the NLRP3 inflammasome pathway
por: Groslambert M, et al.
Publicado: (2018)

Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
por: Choudhury SM, et al.
Publicado: (2021)

Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
por: Jiang Y, et al.
Publicado: (2019)

Melatonin Attenuates Neuroinflammation by Down-Regulating NLRP3 Inflammasome via a SIRT1-Dependent Pathway in MPTP-Induced Models of Parkinson’s Disease
por: Zheng R, et al.
Publicado: (2021)

New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease
por: Zhang J, et al.
Publicado: (2021)

In vitro expression of NLRP inflammasome-induced active Caspase-1 expression in normal human epidermal keratinocytes (NHEK) by various exogenous threats and subsequent inhibition by naturally derived ingredient blends
por: Gruber JV, et al.
Publicado: (2019)

Inflammasome as an Effective Platform for Fibrosis Therapy
por: Chen TT, et al.
Publicado: (2021)

COMPLEX ESTIMATION OF BRONCHOPULMONARY SYSTEM IN PATIENTS WITH HODGKINS LYMPHOMA
por: Yu. N. Obgolts, et al.
Publicado: (2012)

Lycopus lucidus Turcz Exerts Neuroprotective Effects Against H2O2-Induced Neuroinflammation by Inhibiting NLRP3 Inflammasome Activation in Cortical Neurons
por: Kim H, et al.
Publicado: (2021)

Hodgkin's lymphoma
por: E. A. Demina, et al.
Publicado: (2020)

Hydrogen Sulfide Contributes to Uterine Quiescence Through Inhibition of NLRP3 Inflammasome Activation by Suppressing the TLR4/NF-κB Signalling Pathway
por: Chen Z, et al.
Publicado: (2021)

Inflammasomes: Pandora’s box for sepsis
por: Kumar V
Publicado: (2018)

Raoultella ornithinolytica in MALT-type non-Hodgkin Lymphoma
por: Rui Seixas, et al.
Publicado: (2021)

EPIDEMIOLOGY OF NON-HODGKIN’S LYMPHOMAS IN iRKUTSK REGION
por: E. V. Zubkova, et al.
Publicado: (2012)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan Z, et al.
Publicado: (2019)

The Differential Expression of the Inflammasomes in Adipose Tissue and Colon Influences the Development of Colon Cancer in a Context of Obesity by Regulating Intestinal Inflammation
por: Frühbeck G, et al.
Publicado: (2021)

Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation
por: Li N, et al.
Publicado: (2021)

Primary central nervous system Hodgkin Lymphoma: A case discussion and a hypothesis on the etiology
por: Ahmad Alfaseh, et al.
Publicado: (2019)

Analysis of mortality at non-Hodgkin lymphomas in the unit of cancer chemotherapy of Irkutsk Regional Oncologic Dispensary in 2011-2013
por: E. V. Zubkova, et al.
Publicado: (2014)

An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
por: Aroa Baragaño Raneros, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome in Lupus Nephritis
por: Camila Barbosa Oliveira, et al.
Publicado: (2021)

Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens
por: Pezzullo Luca, et al.
Publicado: (2021)

Exposure to nickel oxide nanoparticles induces pulmonary inflammation through NLRP3 inflammasome activation in rats
por: Cao Z, et al.
Publicado: (2016)

"RAPID AND SIMULTANEOUS DETERMINATION OF ADRIAMYCIN, BLEOMYCIN, VINBLASTINE AND DACARBAZINE IN PLASMA OF HODGKIN'S LYMPHOMA PATIENTS BY A REVERSED PHASE HPLC METHOD"
por: ZUBAIR MALIK,MUHAMMAD, et al.
Publicado: (2013)

Regulation of the Immune Microenvironment by an NLRP3 Inhibitor Contributes to Attenuation of Acute Right Ventricular Failure in Rats with Pulmonary Arterial Hypertension
por: Guo L, et al.
Publicado: (2021)

Grape Seed Proanthocyanidin Extract Moderated Retinal Pigment Epithelium Cellular Senescence Through NAMPT/SIRT1/NLRP3 Pathway
por: Zhu W, et al.
Publicado: (2021)

Investigating Markers of the NLRP3 Inflammasome Pathway in Alzheimer’s Disease: A Human Post-Mortem Study
por: Hao Tang, et al.
Publicado: (2021)

Candidalysin Crucially Contributes to Nlrp3 Inflammasome Activation by <named-content content-type="genus-species">Candida albicans</named-content> Hyphae
por: Ona Rogiers, et al.
Publicado: (2019)

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
por: Francesca La Rosa, et al.
Publicado: (2021)

Valor pronóstico del PET/CT interino en Linfoma no Hodgkin en comparación con factores pronósticos clásicos (IPI) y de composición corporal (sarcopenia/lipopenia)
por: Guevara,David Ladrón de, et al.
Publicado: (2020)

Entinostat Improves Motor Function and Neuronal Damage Via Downregulating NLRP3 Inflammasome Activation After Spinal Cord Injury
por: Chen Dai, et al.
Publicado: (2021)

Maternal High-Fat Diet Programs Renal Peroxisomes and Activates NLRP3 Inflammasome-Mediated Pyroptosis in the Rat Fetus
por: Zhou P, et al.
Publicado: (2021)

Synchronous Hodgkin’s Lymphoma and Adenocarcinoma of the Lung with Metachronous Squamous Cell Carcinoma of Esophagus – A Rare Case Report
por: Aswin Nagarajan, et al.
Publicado: (2021)

Ocurrencia de leucemia mieloide crónica y linfoma no Hodgkin en un mismo paciente: Caso clínico
por: Morales F,Eugenia, et al.
Publicado: (1999)

NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells
por: Li T, et al.
Publicado: (2019)

Therapy of Hodgkin lymphoma in Russia during the COVID-19 pandemic
por: Irina V. Poddubnaya, et al.
Publicado: (2020)

S1P/S1P<sub>2</sub> Signaling Axis Regulates Both NLRP3 Upregulation and NLRP3 Inflammasome Activation in Macrophages Primed with Lipopolysaccharide
por: Chi-Ho Lee, et al.
Publicado: (2021)

Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma
por: Oncale MB, et al.
Publicado: (2017)

FEATURES OF THE CUMULATIVE INCIDENCE OF LYMPHOMAS IN DIFFERENT REGIONS OF THE CHERKASY REGION
por: V.V. Paramonov, et al.
Publicado: (2021)

NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
por: Chaoqin Zhong, et al.
Publicado: (2021)